Surendran A, Zsigmond K, Lopez-Perez K, Alain Miranda-Quintana R
bioRxiv. 2025; .
PMID: 40027675
PMC: 11870582.
DOI: 10.1101/2025.02.18.638904.
Bajorath J
J Cheminform. 2024; 16(1):124.
PMID: 39501323
PMC: 11539482.
DOI: 10.1186/s13321-024-00922-0.
Lopez Perez K, Jung V, Chen L, Huddleston K, Alain Miranda-Quintana R
bioRxiv. 2024; .
PMID: 39149242
PMC: 11326248.
DOI: 10.1101/2024.08.10.607459.
Yang Z, Wang Y, Du G, Zhan Y, Zhan W
J Mol Model. 2024; 30(8):264.
PMID: 38995407
DOI: 10.1007/s00894-024-06051-7.
Cankara F, Senyuz S, Sayin A, Gursoy A, Keskin O
J Chem Inf Model. 2024; 64(13):5041-5051.
PMID: 38907989
PMC: 11577314.
DOI: 10.1021/acs.jcim.3c01905.
iSIM: instant similarity.
Lopez-Perez K, Kim T, Alain Miranda-Quintana R
Digit Discov. 2024; 3(6):1160-1171.
PMID: 38873032
PMC: 11167700.
DOI: 10.1039/d4dd00041b.
Standardizing Substrate Selection: A Strategy toward Unbiased Evaluation of Reaction Generality.
Rana D, Pfluger P, Holter N, Tan G, Glorius F
ACS Cent Sci. 2024; 10(4):899-906.
PMID: 38680564
PMC: 11046462.
DOI: 10.1021/acscentsci.3c01638.
ChemMORT: an automatic ADMET optimization platform using deep learning and multi-objective particle swarm optimization.
Yi J, Yang Z, Zhao W, Yang Z, Zhang X, Wu C
Brief Bioinform. 2024; 25(2).
PMID: 38385872
PMC: 10883642.
DOI: 10.1093/bib/bbae008.
Identifying novel inhibitors targeting Exportin-1 for the potential treatment of COVID-19.
Sharma T, Mondal T, Khan S, Patzi Churqui M, Nystrom K, Thombare K
Arch Microbiol. 2024; 206(2):69.
PMID: 38240823
DOI: 10.1007/s00203-023-03761-z.
Making sense of chemical space network shows signs of criticality.
Amoroso N, Gambacorta N, Mastrolorito F, Togo M, Trisciuzzi D, Monaco A
Sci Rep. 2023; 13(1):21335.
PMID: 38049451
PMC: 10696027.
DOI: 10.1038/s41598-023-48107-3.
Computational Chemistry for the Identification of Lead Compounds for Radiotracer Development.
Hsieh C, Giannakoulias S, Petersson E, Mach R
Pharmaceuticals (Basel). 2023; 16(2).
PMID: 37259459
PMC: 9964981.
DOI: 10.3390/ph16020317.
In Vitro Inhibitory Effects and Bioinformatic Analysis of Norfloxacin and Ofloxacin on Piroplasm.
Rizk M, El-Sayed S, Igarashi I
Acta Parasitol. 2022; 68(1):213-222.
PMID: 36539677
DOI: 10.1007/s11686-022-00648-9.
Virtual Extensive Read-Across: A New Open-Access Software for Chemical Read-Across and Its Application to the Carcinogenicity Assessment of Botanicals.
Vigano E, Colombo E, Raitano G, Manganaro A, Sommovigo A, Dorne J
Molecules. 2022; 27(19).
PMID: 36235142
PMC: 9570968.
DOI: 10.3390/molecules27196605.
activity and atom pair fingerprint analysis of MMV665941 against the apicomplexan parasite Babesia microti, the causative agent of babesiosis in humans and rodents.
Rizk M, El-Sayed S, Igarashi I
Pathog Glob Health. 2022; 117(3):315-321.
PMID: 36172647
PMC: 10081058.
DOI: 10.1080/20477724.2022.2128571.
Repurposing of the Malaria Box for Babesia microti in mice identifies novel active scaffolds against piroplasmosis.
Rizk M, Baghdadi H, El-Sayed S, Eltaysh R, Igarashi I
Parasit Vectors. 2022; 15(1):329.
PMID: 36123705
PMC: 9487043.
DOI: 10.1186/s13071-022-05430-4.
Computer-Aided Drug Design Boosts RAS Inhibitor Discovery.
Wang G, Bai Y, Cui J, Zong Z, Gao Y, Zheng Z
Molecules. 2022; 27(17).
PMID: 36080477
PMC: 9457765.
DOI: 10.3390/molecules27175710.
Towards an Enrichment Optimization Algorithm (EOA)-based Target Specific Docking Functions for Virtual Screening.
Spiegel J, Senderowitz H
Mol Inform. 2022; 41(11):e2200034.
PMID: 35790469
PMC: 9786651.
DOI: 10.1002/minf.202200034.
Relational graph convolutional networks for predicting blood-brain barrier penetration of drug molecules.
Ding Y, Jiang X, Kim Y
Bioinformatics. 2022; 38(10):2826-2831.
PMID: 35561199
PMC: 9113341.
DOI: 10.1093/bioinformatics/btac211.
Sequential ligand- and structure-based virtual screening approach for the identification of potential G protein-coupled estrogen receptor-1 (GPER-1) modulators.
Khan S, Ahemad N, Chuah L, Naidu R, Htar T
RSC Adv. 2022; 9(5):2525-2538.
PMID: 35520492
PMC: 9059856.
DOI: 10.1039/c8ra09318k.
Design, synthesis and biological evaluation of novel amide-linked 18β-glycyrrhetinic acid derivatives as novel ALK inhibitors.
Cai D, Zhang Z, Chen Y, Ruan C, Li S, Chen S
RSC Adv. 2022; 10(20):11694-11706.
PMID: 35496614
PMC: 9050490.
DOI: 10.1039/d0ra00681e.